Genomic Biomarkers

Date: Thursday, 19 April 2012 - Friday, 20 April 2012
Location: Boston, USA

Keynote Speakers

Michael Burczynski
Executive Director and Head of Integrated Clinical Biomarker Technologies, Bristol-Myers Squibb

Andrey Loboda
Associate Director, Merck Laboratories

Overview

Welcome to the Genomic Biomarkers track of the Genomics Research conference and exhibition. This year's event will be held in Boston.

The conference aims to look at the various Genomic Biomarker Classes and their role as predictive and prognostic elements in disease research and diagnosis. Particular emphasis will be placed on cancer personalised medicine and looking to see where the commercial trends are moving the market as a whole for the coming years.

Other conference tracks at this event include Advances in qPCR, Epigenetics, Next-Gen Sequencing, and RNAi and miRNA. Registered delegates will have access to all eight meetings ensuring a very cost-effective trip.

In addition the event will also host a cutting edge training course which can be viewed here and two business tutorials which can be viewed here.

Agenda Topics

Cancer Personalised Medicine
Commercial Trends
Gene Expression Biomarkers in Disease
Proteomic Biomarkers in Disease

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Yair Benita, Senior Computational Biologist, Merck Research Laboratories
Han Chang, Principal Scientist, Bristol-Myers Squibb
Marta Dueñas Porto, Senior Researcher, CIEMAT
William Gallaghr, Chief Scientific Officer/Professor, OncoMark Limited/University College Dublin
David Gorenstein, Associate Dean for Research/Founder AM, The University of Texas Health Science Center
Shidong Jia, Scientist, Genentech Inc
Stephen Johnston, Director, Arizona State University
Victor Levenson, Associate Professor, Rush University Medical Center
Mao Mao, Research Fellow, Pfizer Global Research and Development
Yannick Marie, Platform Manager, Universite Pierre et Marie Curie
Robert McMaster, Executive Director/Professor, University of British Columbia
Craig Nelson, Associate Professor, University of Connecticut
Steven Okino, Staff Scientist, Bio-Rad Laboratories
Ben Park, Associate Professor, Johns Hopkins University
Adam Pavlicek, Senior Principal Scientist in Computational Biology, Pfizer
Hoon Ryu, Associate Professor, Boston University School of Medicine
Cornelis Verweij, Professor, VU University Medical Centre
Wenzhong Xiao, Assistant Professor, Massachusetts General Hospital